{"nct_id":"NCT03334487","title":"Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer","status":"WITHDRAWN","status_verified_date":"2018-12","start_date":"2018-03-15","start_date_type":"ACTUAL","primary_completion_date":"2018-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}